These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. Lin TJ; Lin CL; Wang CS; Liu SO; Liao LY World J Gastroenterol; 2005 Jul; 11(25):3905-8. PubMed ID: 15991291 [TBL] [Abstract][Full Text] [Related]
44. An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy. Floreani A; Rosa Rizzotto E; Basso D; Navaglia F; Zaninotto M; Petridis I; DI Andrea O; Testa R; Marra M; Baldo V; Chiaramonte M Aliment Pharmacol Ther; 2007 Aug; 26(4):577-86. PubMed ID: 17661761 [TBL] [Abstract][Full Text] [Related]
45. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls. Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835 [TBL] [Abstract][Full Text] [Related]
46. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls. Byrnes V; Ryan E; O'Keane C; Crowe J Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870 [TBL] [Abstract][Full Text] [Related]
47. Prevalence of HFE mutations among the Thai population and correlation with iron loading in haemoglobin E disorder. Viprakasit V; Vathesathokit P; Chinchang W; Tachavanich K; Pung-Amritt P; Wimhurst VL; Yenchitsomanus PT; Merryweather-Clarke AT; Tanphaichitr VS Eur J Haematol; 2004 Jul; 73(1):43-9. PubMed ID: 15182337 [TBL] [Abstract][Full Text] [Related]
48. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes. Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375 [TBL] [Abstract][Full Text] [Related]
49. Relation between HFE mutations and mild iron-overload expression. Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847 [TBL] [Abstract][Full Text] [Related]
50. [Heterozygosis H63D in patients with steatohepatitis and chronic hepatitis C]. Pulvirenti D; Neri S; Bertino G; Cutuli N; Ignaccolo L; Misseri M; Tsami A; Caruso L Clin Ter; 2006; 157(6):485-8. PubMed ID: 17228846 [TBL] [Abstract][Full Text] [Related]
51. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Njajou OT; Houwing-Duistermaat JJ; Osborne RH; Vaessen N; Vergeer J; Heeringa J; Pols HA; Hofman A; van Duijn CM Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276 [TBL] [Abstract][Full Text] [Related]
52. Prevalence of the H63D mutation of the HFE in north India: its presence does not cause iron overload in beta thalassemia trait. Garewal G; Das R; Ahluwalia J; Marwaha RK Eur J Haematol; 2005 Apr; 74(4):333-6. PubMed ID: 15777346 [TBL] [Abstract][Full Text] [Related]
54. Analysis of HFE and TFR2 mutations in selected blood donors with biochemical parameters of iron overload. De Gobbi M; Daraio F; Oberkanins C; Moritz A; Kury F; Fiorelli G; Camaschella C Haematologica; 2003 Apr; 88(4):396-401. PubMed ID: 12681966 [TBL] [Abstract][Full Text] [Related]
55. An epidemiologic study on the incidence and significance of HFE mutations in a Korean cohort with nonalcoholic fatty liver disease. Lee SH; Jeong SH; Lee D; Lee JH; Hwang SH; Cho YA; Park YS; Hwang JH; Kim JW; Kim N; Lee DH; Kang W J Clin Gastroenterol; 2010 Aug; 44(7):e154-61. PubMed ID: 20216079 [TBL] [Abstract][Full Text] [Related]
56. Frequency and clinical expression of HFE gene mutations in a Spanish population of subjects with abnormal iron metabolism. Gómez-Llorente C; Miranda-León MT; Blanco S; Gandia-Pla S; Gómez-Capilla JA; Fárez-Vidal ME Ann Hematol; 2005 Oct; 84(10):650-5. PubMed ID: 15986199 [TBL] [Abstract][Full Text] [Related]
57. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation. Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617 [TBL] [Abstract][Full Text] [Related]
58. Role of HFE gene mutations on developing iron overload in beta-thalassaemia carriers in Egypt. Madani HA; Afify RA; Abd El-Aal AA; Salama N; Ramy N East Mediterr Health J; 2011 Jun; 17(6):546-51. PubMed ID: 21796974 [TBL] [Abstract][Full Text] [Related]
59. Predicting iron overload in hyperferritinemia. Olynyk JK; Gan E; Tan T Clin Gastroenterol Hepatol; 2009 Mar; 7(3):359-62. PubMed ID: 19095082 [TBL] [Abstract][Full Text] [Related]
60. Hepatic iron loading in patients with compound heterozygous HFE mutations. Lim EM; Rossi E; De Boer WB; Reed WD; Jeffrey GP Liver Int; 2004 Dec; 24(6):631-6. PubMed ID: 15566515 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]